These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 4877410)

  • 41. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
    [No Abstract]   [Full Text] [Related]  

  • 42. [On qualitative demonstration of tuberculostatics in the control of taking of drugs].
    Grunert M; Reutgen H; Iwainsky H
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):141-8. PubMed ID: 5899136
    [No Abstract]   [Full Text] [Related]  

  • 43. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 44. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K; Hayashida M; Ishihara M; Ijichi F; Obata Y
    Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H; Takahashi R; Nakai T; Torii R; Yo I
    Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
    [No Abstract]   [Full Text] [Related]  

  • 47. [Thiacetazone (Tb-1): recent experimental and clinical data].
    Grosset J; Benhassine M
    Bibl Tuberc; 1970; 26():107-53. PubMed ID: 4189928
    [No Abstract]   [Full Text] [Related]  

  • 48. Retreatment of tuberculosis patients with combined drug therapy.
    Feldman J
    Geriatrics; 1969 Nov; 24(11):92-4. PubMed ID: 5349362
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pulmonary tuberculosis caused by Mycobacterium bovis with primary resistance to Isoniazide and pyrazinamide].
    Blanco Ramos JR; Rosel Rioja L; Dopereiro Gómez R; Oteo Revuelta JA
    An Med Interna; 1997 Aug; 14(8):433-4. PubMed ID: 9376493
    [No Abstract]   [Full Text] [Related]  

  • 50. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis.
    Ogawa T; Motomura K
    Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006
    [No Abstract]   [Full Text] [Related]  

  • 52. Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children.
    Steiner M
    Med Clin North Am; 1967 Sep; 51(5):1153-67. PubMed ID: 4297572
    [No Abstract]   [Full Text] [Related]  

  • 53. [Tuberculostatic tolerance of a tuberculous kidney].
    Strauss I
    Z Urol Nephrol; 1969; 62(9):651-6. PubMed ID: 4325816
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of the addition of the 3rd agent on the combined therapy with ethionamide and kanamycin in tuberculosis in the mice].
    Matsumiya T; Freerksen E; Rosenfeld M
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):30-4. PubMed ID: 4991617
    [No Abstract]   [Full Text] [Related]  

  • 55. [Drug therapy of tuberculosis. Advanced training and working conference at the Central Hospital Gauting of the State Insurance Company of Upper Bavaria on Nov. 9, 1968].
    Erhard G
    Med Klin; 1969; 64(26):1215-7. PubMed ID: 4979959
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 57. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 58. [Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations].
    Fedotova ZN; Gur'ian IE; Kochetov BI
    Probl Tuberk; 1972; 50(11):21-4. PubMed ID: 4630564
    [No Abstract]   [Full Text] [Related]  

  • 59. [Microbacterial resistance to antibiotic preparations].
    Savchenko PIu
    Mikrobiol Zh; 1970; 32(3):376-82. PubMed ID: 4996138
    [No Abstract]   [Full Text] [Related]  

  • 60. [Correlation of lipid fractions, toxicity and virulence of M. tuberculosis isolated from patients treated with antibacterial preparations].
    Nemsadze MN
    Probl Tuberk; 1971; 49(11):66-9. PubMed ID: 5004859
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.